MarketLens
Sign Up

What Do LifeMD's Q4 2025 Results Really Tell Us

5 months ago
SHARE THIS ON:

What Do LifeMD's Q4 2025 Results Really Tell Us

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 week ago

Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?

Medifast's coach productivity and client retention gains point to stabilization, though a shrinking coach base still challenges revenue growth. The company's path to revival depends on offsetting coac...
Stock News1 week ago

Astrana Health: 81% Full-Risk And Profitable

Astrana Health trades at a 46% discount to peers, with G&A costs down to 5.57% of revenue from 7.75%, after its Care Enablement platform quadrupled third-party revenue year-over-year.
Stock News2 weeks ago

UPDATE - LifeMD Reports Second Quarter 2026 Results

LifeMD reported Q2 2026 revenue of $47.3 million, within its $47–50 million guidance, and an adjusted EBITDA loss of ~$3.5 million, improving ~21% sequentially.
Stock News1 months ago

Is It Too Late to Buy Eli Lilly?

Eli Lilly's weight loss portfolio generated over $12B in the latest quarter, reinforcing its lead in the high-growth market.

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

Amazon's Toaster-Shaped Robotaxis Are Hitting the Road

Stock News2 hours ago

Tesla Maintained Its Majority of the U.S. EV Market in Q2, but That's Not All You Need to Know

Stock News3 hours ago

David Wagner on MSFT Moat Adding AI Momentum, Azure Backing CapEx Story

Stock News5 hours ago

2 Energy Stocks Riding the Data Center Power Crunch

Stock News8 hours ago

This is One of the Cheapest Magnificent Seven Stocks Right Now